Hyphens Pharma lodges preliminary offer document for Catalist listing

-A +A

SINGAPORE (April 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catalist Board in 2018.

Hyphens Pharma incorporated in Dec 2017 as a private company, and on Apr 20 this year was converted into a public limited company following a restructuring exercise.  

Through its wholly-owned subsidiary Pan-Malayan Pharmaceuticals, the group engages in the wholesale of pharmaceuticals and medical supplies in Singapore via both the conventional business model of tele-sales and sales representatives, as well as an online B2B platform at www.pom.com.sg... (Click here to read the full story)